Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study

Denosumab is a human monoclonal antibody that neutralizes RANKL, a cytokine able to interact with the RANK receptor on preosteoclasts and osteoclasts, decreasing their recruitment and differentiation, leading to a decreased bone resorption. The aim of this observational real-life study was to analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Marocco, Chiara, Zimatore, Giovanna, Mocini, Edoardo, Fornari, Rachele, Iolascon, Giovanni, Gallotta, Maria Chiara, Bimonte, Viviana Maria, Baldari, Carlo, Lenzi, Andrea, Migliaccio, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916792/
https://www.ncbi.nlm.nih.gov/pubmed/33579002
http://dx.doi.org/10.3390/ijerph18041728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916792/
https://www.ncbi.nlm.nih.gov/pubmed/33579002
http://dx.doi.org/10.3390/ijerph18041728

Ejemplares similares